Nasopalatine Duct Cyst, a Delayed Complication to Successful Dental Implant Placement: Diagnosis and Surgical Management

2014 ◽  
Vol 40 (2) ◽  
pp. 189-195 ◽  
Author(s):  
Shane Joseph McCrea

The dental literature reports frequently on both the success and survival of dental implants, whereby the focus remains on the biological response of hard and soft tissue to the implants. The predication and anticipation of adverse implant events can then lead to the preemption of implant loss. However, biological situations can arise that are outside the control of the clinician. The author reports a case history of the late manifestation of a nasopalatine duct cyst in close proximity to a dental implant and its subsequent surgical management.

2016 ◽  
Vol 8 (1) ◽  
pp. 13 ◽  
Author(s):  
HashemMotahir Al-Shamiri ◽  
Samir Elfaki ◽  
SadeqAli Al-Maweri ◽  
NaderAhmed Alaizari ◽  
Bassel Tarakji

Author(s):  
Judd Sher ◽  
Kate Kirkham-Ali ◽  
Denny Luo ◽  
Catherine Miller ◽  
Dileep Sharma

The present systematic review evaluates the safety of placing dental implants in patients with a history of antiresorptive or antiangiogenic drug therapy. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. PubMed, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and OpenGrey databases were used to search for clinical studies (English only) to July 16, 2019. Study quality was assessed regarding randomization, allocation sequence concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases using a modified Newcastle-Ottawa scale and the Joanna Briggs Institute critical appraisal checklist for case series. A broad search strategy resulted in the identification of 7542 studies. There were 28 studies reporting on bisphosphonates (5 cohort, 6 case control, and 17 case series) and one study reporting on denosumab (case series) that met the inclusion criteria and were included in the qualitative synthesis. The quality assessment revealed an overall moderate quality of evidence among the studies. Results demonstrated that patients with a history of bisphosphonate treatment for osteoporosis are not at increased risk of implant failure in terms of osseointegration. However, all patients with a history of bisphosphonate treatment, whether taken orally for osteoporosis or intravenously for malignancy, appear to be at risk of ‘implant surgery-triggered’ MRONJ. In contrast, the risk of MRONJ in patients treated with denosumab for osteoporosis was found to be negligible. In conclusion, general and specialist dentists should exercise caution when planning dental implant therapy in patients with a history of bisphosphonate and denosumab drug therapy. Importantly, all patients with a history of bisphosphonates are at risk of MRONJ, necessitating this to be included in the informed consent obtained prior to implant placement. The James Cook University College of Medicine and Dentistry Honours program and the Australian Dental Research Foundation Colin Cormie Grant were the primary sources of funding for this systematic review.


2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Algirdas Puisys ◽  
Viktorija Auzbikaviciute ◽  
Renata Simkunaite-Rizgeliene ◽  
Dainius Razukevicius ◽  
Rokas Linkevicius ◽  
...  

The aim of this case report is to show that bone remineralization around dental implants with a history of peri-implantitis is possible after irritant factors are removed and only conservative treatment is performed. Patient came to the clinic after three years of dental implant placement complaining about swelling, sensitivity and gingiva color changes at the posterior part of the maxilla. During radiographic and intraoral examinations peri-implantitis of the #24 implant site was diagnosed. The surgical treatment method was rejected and performed conservative treatment instead. The outcome is promising; periapical radiographs three months later showed bone remineralization as well as stable bone after 10 years. A key clinical message: Bone remineralization around dental implants with a history of peri-implantitis is possible after irritant factors are removed and conservative treatment performed.


2015 ◽  
Vol 1 (3) ◽  
pp. 38-41 ◽  
Author(s):  
Shintaro Sukegawa ◽  
Takahiro Kanno ◽  
Hotaka Kawai ◽  
Yuichiro Takebe ◽  
Akane Shibata ◽  
...  

Single or multiple dental implants have become a well-accepted method of replacement of missing teeth and their supporting structures. This chapter introduces implantology, with an explanation of the history of dental implants and a discussion regarding the need to replace missing teeth. The key aspects of treatment planning for implants are outlined including assessment of suitability for implant placement, indications, and contraindications. Available implant types are outlined and the risks of implant placement such as failure to osseointegrate, gingival recession, and nerve damage are considered. Basic surgical techniques for implant placement are described including an explanation of healing and integration times. The chapter includes provision, follow-up, and maintenance advice regarding restoration of the dental implant.


2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Gustavo Maluf ◽  
Rogério Jardim Caldas ◽  
Eduardo Rodrigues Fregnani ◽  
Paulo Sérgio da Silva Santos

Abstract Background Medication-related osteonecrosis of the jaw (MRONJ) is characterized by the development of bone necrosis in the jaws of patients receiving antiresorptive and/or antiangiogenic medications. No scientific reports have been published yet on bevacizumab-related osteonecrosis of the jaw (BeRONJ) when associated with dental implant placement and adjuvant ozone therapy. Case presentation A 54-year-old female patient with a history of metastatic breast cancer and bevacizumab use presented with a dental infection. Dental extraction followed immediately by dental implant placement was planned after suspension of the bevacizumab treatment. The patient presented with pain, drainage of purulent secretion, and bone exposure 5 weeks post-surgery. Complete healing was achieved at postoperative 7 months. Conclusions The combination of adjuvant ozone therapy and surgical debridement was effective for the treatment of MRONJ; however, the risk of MRONJ may persist after the suspension of bevacizumab for 28 days.


2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Víctor Beltrán ◽  
Mario Cantín ◽  
Eduardo Borie ◽  
Ramón Fuentes ◽  
Wilfried Engelke

The surgical removal of supernumerary teeth is necessary in some cases, especially before the commencement of any orthodontic or implant treatment procedure. In the mandibular supernumerary premolar, a more conservative approach is required because of the presence of complications associated with conventional surgery due to the close proximity of the said premolar to the alveolar inferior and mental nerves, and the need for bone conservation for implant placement. The endoscopic surgical approach has been used for the removal of the maxillary supernumerary tooth, impacted third molar, and implants. In this case report, we present an endoscopically assisted surgical technique for the removal of an unerupted supernumerary premolar in the mandible associated with a dental implant placement procedure.


Author(s):  
Umberto Uccioli ◽  
Alberto Fonzar ◽  
Stefania Lanzuolo ◽  
Silvio Mario Meloni ◽  
Aurea Lumbau ◽  
...  

The purpose of this case report was to present a combination of two procedures in the treatment of gingival recessions after implant placement in the anterior maxilla. Decision making process and step-by-step execution of the treatments were presented to describe the clinical and surgical management of the reported case.


Sign in / Sign up

Export Citation Format

Share Document